This is the authors' abstract. We don't add key points for this paper.
Kidney biopsy is still the gold standard in renal disease to provide diagnosis and prognosis, and to guide treatment.1 Like any invasive procedure, it has complications (4%−5%), mainly related to bleeding or development of arteriovenous fistulas.2,3
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Barrios et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: